STTK insider trading

NasdaqGS Healthcare

Shattuck Labs, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
199
Last 90 days
9
Buys / sells
11% / 39%
Market cap
$430.82M

About Shattuck Labs, Inc.

Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Company website: www.shattucklabs.com

STTK insider activity at a glance

FilingIQ has scored 199 insider transactions for STTK since Oct 14, 2020. The most recent filing in our index is dated May 12, 2026.

Across the full history, 21 open-market purchases and 78 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on STTK insider trades is 54.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest STTK Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for STTK?
FilingIQ tracks 199 Form 4 insider transactions for STTK (Shattuck Labs, Inc.), covering filings from Oct 14, 2020 onwards. 9 of those were filed in the last 90 days.
Are STTK insiders net buyers or net sellers?
Across the full Form 4 history for STTK, 21 transactions (11%) were open-market purchases and 78 (39%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does STTK insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is STTK in?
Shattuck Labs, Inc. (STTK) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $430.82M.

Methodology & sources

Every STTK insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.